[Federal Register Volume 76, Number 198 (Thursday, October 13, 2011)]
[Notices]
[Pages 63622-63623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-26477]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee, 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Times and Dates:
    9 a.m.-5 p.m., November 3, 2011.
    9 a.m.-12 p.m., November 4, 2011.
    Place: Embassy Suites-Washington, DC Convention Center, Capital 
CD Room, 900 10th Street, NW., Washington, DC 2000.
    Status: Open to the public, limited only by the space available. 
Please register for the meeting at http://www.cdc.gov/hicpac.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, the Director, National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), and the Director, Division of 
Healthcare Quality Promotion regarding (1) The practice of 
healthcare infection control; (2) strategies for surveillance, 
prevention, and control of infections (e.g., nosocomial infections), 
antimicrobial resistance, and related events in settings where 
healthcare is provided; and (3) periodic updating of guidelines and 
other policy statements regarding prevention of healthcare-
associated infections and healthcare-related conditions.
    Matters To Be Discussed: The agenda will include updates on 
CDC's activities for healthcare associated infections, draft 
guideline for prevention of infections among patients in neonatal 
intensive care units (NICU), draft guideline for infection control 
in healthcare personnel, draft guideline for the prevention of 
surgical site infections, update from the HICPAC surveillance 
working group, and guidance for control of Carbapenem-resistant 
Enterobacteriaceae.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Heidi Williams, HICPAC, 
Division of Healthcare

[[Page 63623]]

Quality Promotion, NCEZID, CDC, 1600 Clifton Road, NE., Mailstop A-
07, Atlanta, Georgia 30333, E-mail: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: October 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-26477 Filed 10-12-11; 8:45 am]
BILLING CODE 4163-18-P